Informazioni generali
  • Categoria della malattia Demenza e morbo di Alzheimer (BASEC)
  • Fase dello studio N/A (ICTRP)
  • Stato di reclutamento reclutamento in corso (BASEC/ICTRP)
  • Luogo dello studio
    Losanna
    (BASEC)
  • Responsabile dello studio Patrizia D'Amelio patrizia.damelio@chuv.ch (BASEC)
  • Fonte dati BASEC: Importato da 19.06.2025 ICTRP: Importato da 25.04.2025
  • Ultimo aggiornamento 19.06.2025 16:51
HumRes65164 | SNCTP000005963 | BASEC2023-01092 | NCT05691569

Effectiveness of doll therapy in controlling behavioral and psychological symptoms of dementia: the AGITATE study.

  • Categoria della malattia Demenza e morbo di Alzheimer (BASEC)
  • Fase dello studio N/A (ICTRP)
  • Stato di reclutamento reclutamento in corso (BASEC/ICTRP)
  • Luogo dello studio
    Losanna
    (BASEC)
  • Responsabile dello studio Patrizia D'Amelio patrizia.damelio@chuv.ch (BASEC)
  • Fonte dati BASEC: Importato da 19.06.2025 ICTRP: Importato da 25.04.2025
  • Ultimo aggiornamento 19.06.2025 16:51

Descrizione riassuntiva dello studio

Behavioral and psychological symptoms of dementia (BPSD) represent a significant burden for patients and their families. BPSD worsen during hospitalization and require the administration of psychotropics, which are often insufficient to control them and can cause serious side effects. A non-pharmacological approach is recommended as a first-line treatment for BPSD. The AGITATE study will test the effectiveness of doll therapy (DT) to reduce BPSD, particularly agitation and aggression (A/A) in patients with moderate or severe dementia hospitalized in geriatrics. The project's objectives are to evaluate the effect of DT on: patient agitation and aggression, patient quality of life, workload for professionals and families, quality of life for family members assisting the patient. The effectiveness of DT will be assessed by randomly assigning the patient to DT or to a treatment with a cushion that has no human appearance but whose weight and tactile sensation are similar to that of the doll. The study will last 36 months. Geriatric patients hospitalized in the acute geriatric unit of the Lausanne University Hospital (CHUV) will be recruited. The presence of A/A and other BPSD will be assessed using appropriate scales at baseline, at the end, and 1 and 4 weeks after hospitalization. The presence of delirium will also be diagnosed. We will also evaluate the quality of life of patients and families, as well as mood at the beginning and end of the study. The workload and stress of professionals and family members caring for the patient will also be evaluated. Patients and families will be assessed at inclusion, at discharge from the hospital, one week after discharge, and four weeks after. To obtain significant results, we will recruit 120 patients.

(BASEC)

Intervento studiato

The doll used in the study is the "empathy doll"; these dolls are designed to achieve optimal interaction with patients and to elicit empathy. The administration of DT will be standardized. In the control group, a non-anthropomorphic object (a soft cushion) will be used according to the same protocol as the doll. If agitation persists, psychotropic medications will be administered as needed, in accordance with standard clinical practices.

(BASEC)

Malattie studiate

Moderate or severe dementia complicated by behavioral and psychological symptoms, particularly agitation and aggression

(BASEC)

Criteri di partecipazione
Patients: age ≥ 65 years; diagnosis of moderate to severe dementia according to the Clinical Dementia Rating (CDR) ≥ 2; presence of agitation and/or aggression; sufficient manual and visual abilities to interact with the doll. Direct informed consent, documented by the signature of the patient's delegate. Family members of patients: willing to participate in the study, age ≥ 18 years, good understanding of French. (BASEC)

Criteri di esclusione
Patients: age < 65 years; refusal to participate; mild forms of dementia (CDR < 2); contraindication to DT such as a bereavement or trauma experience related to parenting; life expectancy less than 3 months; infectious diseases requiring isolation; negative interaction with the doll; presence of delirium. Family members of patients: refusal to give their consent. (BASEC)

Luogo dello studio

Losanna

(BASEC)

Switzerland (ICTRP)

Sponsor

CHUV

(BASEC)

Contatto per ulteriori informazioni sullo studio

Persona di contatto in Svizzera

Patrizia D'Amelio

+410213143712

patrizia.damelio@chuv.ch

centre hospitalier et Universitaire Vaudoise

(BASEC)

Informazioni generali

+41213143712+41213143712

patrizia.damelio@chuv.ch

(ICTRP)

Nome del comitato etico approvante (per studi multicentrici solo il comitato principale)

Commissione d'etica Vaud

(BASEC)

Data di approvazione del comitato etico

25.06.2024

(BASEC)


ID di studio ICTRP
NCT05691569 (ICTRP)

Titolo ufficiale (approvato dal comitato etico)
Efficacy of Doll therapy in the control of behAvioral and psycholoGIcal sympToms of dementiA in acuTe gEriatric inpatients: the AGITATE study. (BASEC)

Titolo accademico
Efficacy of Doll Therapy in the Control of Behavioral and psychologIcal Symptoms of Dementia in Acute Geriatric Inpatients: the AGITATE Study. (ICTRP)

Titolo pubblico
Efficacy of Doll Therapy in the Dementia in Acute Geriatric Inpatients (ICTRP)

Malattie studiate
Dementia (ICTRP)

Intervento studiato
Other: doll therapy (ICTRP)

Tipo di studio
Interventional (ICTRP)

Disegno dello studio
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label). (ICTRP)

Criteri di inclusione/esclusione
Inclusion Criteria:

- age =65 years

- diagnosis of dementia moderate to severe Clinical Dementia Rating scale (CDR) =2

- presence of agitation and/or aggressiveness

- manual and visual abilities sufficient in order to interact with the doll.

Exclusion Criteria:

- age <65 years

- refuse to participate

- mild forms of dementia (CDR<2)

- contraindication for DT as experience of mournful or traumatic events related to
parental experience

- life expectancy lower than 3 months

- infectious diseases requiring isolation

- negative interaction with the doll,

- presence of delirium. (ICTRP)

non disponibile

Endpoint primari e secondari
agitation and aggressiveness within hospital;behavioural and psychological symptoms of dementia;agitation and aggressiveness outside hospital (ICTRP)

incidence of delirium;patients' quality of life;family caregivers' quality of life;professional caregiver burden;family caregiver burden (ICTRP)

Data di registrazione
29.11.2022 (ICTRP)

Inclusione del primo partecipante
non disponibile

Sponsor secondari
non disponibile

Contatti aggiuntivi
Patrizia D Amelio, MD, PhDPatrizia D'Amelio, MD, PhD, patrizia.damelio@chuv.chpatrizia.damelio@chuv.ch, +41213143712+41213143712 (ICTRP)

ID secondari
agitate (ICTRP)

Risultati-Dati individuali dei partecipanti
non disponibile

Ulteriori informazioni sullo studio
https://clinicaltrials.gov/ct2/show/NCT05691569 (ICTRP)

Risultati dello studio

Riepilogo dei risultati

non disponibile

Link ai risultati nel registro primario

non disponibile